ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Therapy for Breast Cancer Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-2N13512
Home | Market Reports | Health| Health Conditions| Cancer
Global Targeted Therapy for Breast Cancer Market Research Report 2023
BUY CHAPTERS

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Code: QYRE-Auto-2N13512
Report
January 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly and Company
Roche
Merck
Novartis
Pfizer Inc
Merck KGaA
Astellas
Janssen Biotech
Bristol–Myers Squibb
Gilead Sciences

Targeted Therapy for Breast Cancer Market Size

The global market for Targeted Therapy for Breast Cancer was valued at US$ 7148 million in the year 2024 and is projected to reach a revised size of US$ 14070 million by 2031, growing at a CAGR of 10.3% during the forecast period.

Targeted Therapy for Breast Cancer Market

Targeted Therapy for Breast Cancer Market

Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Targeted Therapy for Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Therapy for Breast Cancer.
The Targeted Therapy for Breast Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Therapy for Breast Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Therapy for Breast Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Therapy for Breast Cancer Market Report

Report Metric Details
Report Name Targeted Therapy for Breast Cancer Market
Accounted market size in year US$ 7148 million
Forecasted market size in 2031 US$ 14070 million
CAGR 10.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech, Bristol-Myers Squibb, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Therapy for Breast Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Therapy for Breast Cancer Market growing?

Ans: The Targeted Therapy for Breast Cancer Market witnessing a CAGR of 10.3% during the forecast period 2025-2031.

What is the Targeted Therapy for Breast Cancer Market size in 2031?

Ans: The Targeted Therapy for Breast Cancer Market size in 2031 will be US$ 14070 million.

Who are the main players in the Targeted Therapy for Breast Cancer Market report?

Ans: The main players in the Targeted Therapy for Breast Cancer Market are Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech, Bristol-Myers Squibb, Gilead Sciences

What are the Application segmentation covered in the Targeted Therapy for Breast Cancer Market report?

Ans: The Applications covered in the Targeted Therapy for Breast Cancer Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Targeted Therapy for Breast Cancer Market report?

Ans: The Types covered in the Targeted Therapy for Breast Cancer Market report are Brand Drugs, Generic Drug

Recommended Reports

Targeted Therapy Drugs

Breast Cancer Market

Cancer Therapy Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Targeted Therapy for Breast Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Therapy for Breast Cancer Market Perspective (2020-2031)
2.2 Global Targeted Therapy for Breast Cancer Growth Trends by Region
2.2.1 Global Targeted Therapy for Breast Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Therapy for Breast Cancer Historic Market Size by Region (2020-2025)
2.2.3 Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2026-2031)
2.3 Targeted Therapy for Breast Cancer Market Dynamics
2.3.1 Targeted Therapy for Breast Cancer Industry Trends
2.3.2 Targeted Therapy for Breast Cancer Market Drivers
2.3.3 Targeted Therapy for Breast Cancer Market Challenges
2.3.4 Targeted Therapy for Breast Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue
3.1.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue (2020-2025)
3.1.2 Global Targeted Therapy for Breast Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Therapy for Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Therapy for Breast Cancer Revenue
3.4 Global Targeted Therapy for Breast Cancer Market Concentration Ratio
3.4.1 Global Targeted Therapy for Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Therapy for Breast Cancer Revenue in 2024
3.5 Global Key Players of Targeted Therapy for Breast Cancer Head office and Area Served
3.6 Global Key Players of Targeted Therapy for Breast Cancer, Product and Application
3.7 Global Key Players of Targeted Therapy for Breast Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Therapy for Breast Cancer Breakdown Data by Type
4.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Type (2020-2025)
4.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2026-2031)
5 Targeted Therapy for Breast Cancer Breakdown Data by Application
5.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Application (2020-2025)
5.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Therapy for Breast Cancer Market Size (2020-2031)
6.2 North America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Therapy for Breast Cancer Market Size by Country (2020-2025)
6.4 North America Targeted Therapy for Breast Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Therapy for Breast Cancer Market Size (2020-2031)
7.2 Europe Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Therapy for Breast Cancer Market Size by Country (2020-2025)
7.4 Europe Targeted Therapy for Breast Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Therapy for Breast Cancer Market Size (2020-2031)
8.2 Asia-Pacific Targeted Therapy for Breast Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Therapy for Breast Cancer Market Size (2020-2031)
9.2 Latin America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2020-2025)
9.4 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Therapy for Breast Cancer Market Size (2020-2031)
10.2 Middle East & Africa Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Introduction
11.1.4 Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.1.5 Eli Lilly and Company Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Targeted Therapy for Breast Cancer Introduction
11.2.4 Roche Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Targeted Therapy for Breast Cancer Introduction
11.3.4 Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.3.5 Merck & Co. Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Targeted Therapy for Breast Cancer Introduction
11.4.4 Novartis Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Targeted Therapy for Breast Cancer Introduction
11.5.4 Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Targeted Therapy for Breast Cancer Introduction
11.6.4 Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.6.5 Merck KGaA Recent Development
11.7 Astellas
11.7.1 Astellas Company Details
11.7.2 Astellas Business Overview
11.7.3 Astellas Targeted Therapy for Breast Cancer Introduction
11.7.4 Astellas Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.7.5 Astellas Recent Development
11.8 Janssen Biotech
11.8.1 Janssen Biotech Company Details
11.8.2 Janssen Biotech Business Overview
11.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Introduction
11.8.4 Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.8.5 Janssen Biotech Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Introduction
11.9.4 Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Details
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Introduction
11.10.4 Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2020-2025)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly and Company
Roche
Merck
Novartis
Pfizer Inc
Merck KGaA
Astellas
Janssen Biotech
Bristol–Myers Squibb
Gilead Sciences
List of Tables
 Table 1. Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Brand Drugs
 Table 3. Key Players of Generic Drug
 Table 4. Global Targeted Therapy for Breast Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Targeted Therapy for Breast Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Targeted Therapy for Breast Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Targeted Therapy for Breast Cancer Market Share by Region (2020-2025)
 Table 8. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Targeted Therapy for Breast Cancer Market Share by Region (2026-2031)
 Table 10. Targeted Therapy for Breast Cancer Market Trends
 Table 11. Targeted Therapy for Breast Cancer Market Drivers
 Table 12. Targeted Therapy for Breast Cancer Market Challenges
 Table 13. Targeted Therapy for Breast Cancer Market Restraints
 Table 14. Global Targeted Therapy for Breast Cancer Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Targeted Therapy for Breast Cancer Market Share by Players (2020-2025)
 Table 16. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2024)
 Table 17. Ranking of Global Top Targeted Therapy for Breast Cancer Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Targeted Therapy for Breast Cancer Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Targeted Therapy for Breast Cancer, Headquarters and Area Served
 Table 20. Global Key Players of Targeted Therapy for Breast Cancer, Product and Application
 Table 21. Global Key Players of Targeted Therapy for Breast Cancer, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Targeted Therapy for Breast Cancer Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2020-2025)
 Table 25. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2026-2031)
 Table 27. Global Targeted Therapy for Breast Cancer Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2020-2025)
 Table 29. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2026-2031)
 Table 31. North America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Targeted Therapy for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Targeted Therapy for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Targeted Therapy for Breast Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Eli Lilly and Company Company Details
 Table 47. Eli Lilly and Company Business Overview
 Table 48. Eli Lilly and Company Targeted Therapy for Breast Cancer Product
 Table 49. Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 50. Eli Lilly and Company Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Targeted Therapy for Breast Cancer Product
 Table 54. Roche Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Merck & Co. Company Details
 Table 57. Merck & Co. Business Overview
 Table 58. Merck & Co. Targeted Therapy for Breast Cancer Product
 Table 59. Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 60. Merck & Co. Recent Development
 Table 61. Novartis Company Details
 Table 62. Novartis Business Overview
 Table 63. Novartis Targeted Therapy for Breast Cancer Product
 Table 64. Novartis Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 65. Novartis Recent Development
 Table 66. Pfizer Company Details
 Table 67. Pfizer Business Overview
 Table 68. Pfizer Targeted Therapy for Breast Cancer Product
 Table 69. Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 70. Pfizer Recent Development
 Table 71. Merck KGaA Company Details
 Table 72. Merck KGaA Business Overview
 Table 73. Merck KGaA Targeted Therapy for Breast Cancer Product
 Table 74. Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 75. Merck KGaA Recent Development
 Table 76. Astellas Company Details
 Table 77. Astellas Business Overview
 Table 78. Astellas Targeted Therapy for Breast Cancer Product
 Table 79. Astellas Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 80. Astellas Recent Development
 Table 81. Janssen Biotech Company Details
 Table 82. Janssen Biotech Business Overview
 Table 83. Janssen Biotech Targeted Therapy for Breast Cancer Product
 Table 84. Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 85. Janssen Biotech Recent Development
 Table 86. Bristol-Myers Squibb Company Details
 Table 87. Bristol-Myers Squibb Business Overview
 Table 88. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product
 Table 89. Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 90. Bristol-Myers Squibb Recent Development
 Table 91. Gilead Sciences Company Details
 Table 92. Gilead Sciences Business Overview
 Table 93. Gilead Sciences Targeted Therapy for Breast Cancer Product
 Table 94. Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2020-2025) & (US$ Million)
 Table 95. Gilead Sciences Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Targeted Therapy for Breast Cancer Picture
 Figure 2. Global Targeted Therapy for Breast Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Therapy for Breast Cancer Market Share by Type: 2024 VS 2031
 Figure 4. Brand Drugs Features
 Figure 5. Generic Drug Features
 Figure 6. Global Targeted Therapy for Breast Cancer Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Targeted Therapy for Breast Cancer Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Targeted Therapy for Breast Cancer Report Years Considered
 Figure 12. Global Targeted Therapy for Breast Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Targeted Therapy for Breast Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Targeted Therapy for Breast Cancer Market Share by Region: 2024 VS 2031
 Figure 15. Global Targeted Therapy for Breast Cancer Market Share by Players in 2024
 Figure 16. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Targeted Therapy for Breast Cancer Revenue in 2024
 Figure 18. North America Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Targeted Therapy for Breast Cancer Market Share by Country (2020-2031)
 Figure 20. United States Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Targeted Therapy for Breast Cancer Market Share by Country (2020-2031)
 Figure 24. Germany Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Targeted Therapy for Breast Cancer Market Share by Region (2020-2031)
 Figure 32. China Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Targeted Therapy for Breast Cancer Market Share by Country (2020-2031)
 Figure 40. Mexico Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Targeted Therapy for Breast Cancer Market Share by Country (2020-2031)
 Figure 44. Turkey Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Targeted Therapy for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Eli Lilly and Company Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 48. Roche Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 49. Merck & Co. Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 52. Merck KGaA Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 53. Astellas Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 54. Janssen Biotech Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 56. Gilead Sciences Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Breast Cancer Targeted Drug Market Research Report 2025
Global Cancer Targeted Drug Market Research Report 2025
Global Oncology Targeted Therapy Market Research Report 2025
Global Targeted Therapy for Brain Cancer Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Drug Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Targeted Cancer Therapy Market Research Report 2024
Global Targeted Therapy for Bladder Cancer Market Research Report 2025
Cancer Treatment Drugs Market
Global Breast Cancer Screening Market Research Report 2025
Global Targeted Antitumor Drugs Market Research Report 2025
Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Breast Cancer Drugs Market Insights Forecast to 2030
Global Immuno oncology Clinical Trials Market Research Report 2024
Global Brain Cancer Targeted Drug Market Research Report 2025
Global Targeted Oncology Drugs Market Research Report 2024
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bladder Cancer Targeted Drug Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions